(58) Additionally, by permitting generic drug
manufacturers to update the safety information on their drugs' labels, the proposed rule would significantly accelerate distributing new information about generic drug
safety to healthcare providers and consumers.
TechNavio's analysts forecast the Generic Drugs
market in Japan to grow at a CAGR of 8.16 percent over the period 2014-2019.
On November 13, 2013, the Food and Drug Administration ("FDA") proposed a rule that would reestablish failure to warn liability for generic drug
Indeed, while on the whole the agency takes the party line on generic drugs
' equivalency to branded drugs, the FDA has also stated: "FDA is aware that there are reports that some people may experience an undesired effect when switching from a brand name drug to a generic formulation or from one generic drug
to another generic drug
The suit initially focused on only two drugs and a handful of leading generic drug
manufacturers--Heritage Pharmaceuticals, Aurobindo Pharma USA, Citron Pharma, Mayne Pharma (USA), Mylan Pharmaceuticals, and Teva Pharmaceuticals USA.
In their filing, the professors defended the law's constitutionality, calling it the state's limited response to increases in generic drug
prices unrelated to higher production costs and which occurred when competition for a specific pharmaceutical was limited to three or fewer manufacturers.
Although they may not be associated with a particular company, generic drugs
are usually subject to government regulations in the countries in which they are dispensed.
Based upon recent generic drug
bid activity and on anticipated generic drug
market conditions for the balance of the year, generic drug
purchasing efficiencies are expected to be significantly below Rite Aid's previous experience and will not meet the company's expectations for the year.
Results showed that 76.5% of faculties knew that generic drug
can be used in place of innovator (patented) drug.
Dan Liljenquist, J.D., from Intermountain Healthcare in Salt Lake City, and colleagues discuss generic drug
market failure, whereby a generic drug
manufacturer increases the drug price, which can compromise care.
One key aspect of our role is to strengthen and enhance the overall generic drug